Conference Announcement
MIAMI, Florida – January 29, 2024 – The International Society for Stem Cell Application (ISSCA), a globally recognized leader in regenerative medicine, is delighted to announce its forthcoming regenerative medicine conference in Termez city, Republic of Uzbekistan. The theoretical conference is scheduled to take place on March 4-5, 2024, at the conference hall of the International Research Center Imam Termeziy.
Strategic Partnership
ISSCA has established a strategic partnership with the Ministry of Health of the Republic of Uzbekistan, specifically the Termez branch of Tashkent Medical Academy (Ozbekiston Respublikasi Sogliqni Saqlash Vazirligi), to organize this impactful event. This collaboration exemplifies the shared commitment of ISSCA and the Ministry of Health to advancing healthcare through the dissemination of knowledge in the field of regenerative medicine in the region.
Conference Objectives
The primary objective of the conference is to bring together experts from diverse backgrounds in regenerative medicine, fostering collaboration between science and practice. Distinguished foreign scientists specializing in regenerative medicine, cell therapy applications in degenerative diseases, transplantation, traumatology, dermatology, neuroimmune diseases, and rehabilitation will be in attendance.
Key Focus Areas of the Conference Program
A panel of esteemed experts on stem cells and regenerative medicine will feature at the conference. They will conduct a two-day rigorous research-based discussion on vital topics covering stem cells and regenerative medicine. World-class medical experts in regenerative medicine will share their skills and experience during the theoretical session. The conference will feature esteemed speakers from Turkey, Uzbekistan, and the USA. The conference will focus on a wide range of topics, including:
- Regenerative medicine – the need for knowledge in various fields of medicine
- Exosomes/Extracellular Vesicles
- Mesenchymal stem/stromal cells
- Hematopoietic stem/progenitor cells and engineering
- Gene editing/Gene therapy
- Immunotherapy (CAR-Ts, T Reg, NK cells, etc.)
- Tissue engineering
- Embryonic, organ, and other tissue-specific stem cells
- Application of biomedical cell products in organ and tissue transplantation
- Immunologic aspects of cell therapy for human diseases
- Knowledge in the field of the application of mesenchymal stromal cells in medical practice
ISSCA Leadership’s Insights
Dr. Salih Yildirim
Dr. Salih Yildirim, ISSCA president, expressed his eagerness to share his expertise, stating, “Regenerative medicine is a fast-paced field experiencing exponential growth with ongoing research and product advancements worldwide. We are thrilled to collaborate with the Termez branch of Tashkent Medical Academy to host this conference.”
Benito Novas
Benito Novas, Founder of Global Stem Cells Group and head of public relations at ISSCA, added, “ISSCA’s mission is to share regenerative medicine’s benefits worldwide, supporting patients and physicians in harnessing its power globally.”
A Unique Platform for Knowledge Exchange
The conference expects to be a unique platform for knowledge exchange, collaboration, and advancements in the field of regenerative medicine. ISSCA invites professionals, researchers, and enthusiasts to join this groundbreaking event in the pursuit of enhancing global healthcare through cutting-edge regenerative medicine practices.
For more information, please visit ISSCA Conference – Tashkent, March 2024.
Final Words About the Conference
Regenerative medicine is rapidly growing with continuous explorations revealing new protocols and products. The conference aims to keep participants updated with the industry’s most recent changes and advancements, empowering them to explore more opportunities and be part of a valuable stem cell community.
Contact Information
Learn more about ISSCA and advancements in stem cell therapy by visiting our website or emailing us at info@stemcellsgroup.com.
About the Termiz Branch of the Tashkent Medical Academy
Established in 2018, the Termiz branch of the Tashkent Medical Academy aims to produce highly skilled medical professionals meeting global standards. Committed to academic excellence, the branch offers opportunities for teachers to obtain scientific degrees through research, conducting doctoral dissertations, and anticipates a progressive increase in research activities, solidifying its role in shaping Uzbekistan’s healthcare future.
About ISSCA
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians who aspire to treat diseases and lessen human suffering through advances in science, technology, and the practice of regenerative medicine. ISSCA serves its members through advancements made in the specialty of regenerative medicine. The mission of ISSCA is to establish itself as a global leader in regenerative medicine certification, education, research, and training. ISSCA provides certification training in cities worldwide because it recognizes the importance of standards and certifications in regenerative medicine as a medical specialty. To help more people, both locally and globally, as the demand for more doctors interested in and comfortable with regenerative medicine surges. ISSCA’s mission is to advance quality and uniformity in regenerative medicine worldwide.
About Global Stem Cells Group
The Global Stem Cell Group is a family of several companies focused on stem cell medicine and research. The company uses its network to bring leadership in regenerative medicine training, research, and patient applications. GSCG’s mission is to allow physicians to present the benefits of stem cell medicine to patients worldwide. The company also partners with policymakers, educators, and regulators to promote regenerative medicine. Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. Learn more about Global Stem Cells Group, Inc.’s companies by visiting our website or calling +1 305 560 5331.
Safe Harbor Statement
Statements in this news release may be “forward-looking statements.” Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other information relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates, and projections about our business based partly on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may and are likely to differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release, and The Global Stem Cells Group undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release. This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
